{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T09:47:44Z","timestamp":1791884864824,"version":"4.3.4"},"reference-count":20,"publisher":"Bentham Science Publishers Ltd.","issue":"1","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CDS"],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Patients with inflammatory disease treated with biological agents are at\nan increased risk of developing various adverse effects. However, little is known about the risk\nof nephrotoxicity, such as induced tubulointerstitial nephritis and immune-mediated inflammatory\ndiseases involving the interstitium and renal tubule.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case Presentation:<\/jats:title>\n                    <jats:p>We herein describe a case of biopsy-proven tubulointerstitial nephritis, induced by\nPR3-ANCA-associated vasculitis following adalimumab therapy in a patient with Crohn's disease\nand ankylosing spondylitis. We review the current evidence on adalimumab-induced nephrotoxicity\nand the potential underlying mechanisms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Monitoring of renal function is strongly recommended in all patients treated with\nadalimumab. Early diagnosis of drug-induced tubulointerstitial nephritis due to vasculitis and\nimmediate withdrawal of the offending drug are key to renal recovery and prevention from irreversible\nserious organ damage.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0115748863362460250220172535","type":"journal-article","created":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T01:37:08Z","timestamp":1746409028000},"update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Tubulointerstitial Nephritis in ANCA-Associated Vasculitis as a Rare Adverse Effect of Adalimumab: A Case Report"],"prefix":"10.2174","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7361-8248","authenticated-orcid":true,"given":"Myriam","family":"Ayari","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, Internal Security Forces Hospital La Marsa, Tunis, Tunisia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maha","family":"Mtir","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Internal Security Forces Hospital La Marsa, Tunis, Tunisia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ikram","family":"Mami","sequence":"additional","affiliation":[{"name":"Department ofNephrology, La Rabta Hospital, Tunis, Tunisia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lamia","family":"Rais","sequence":"additional","affiliation":[{"name":"Department ofNephrology, La Rabta Hospital, Tunis, Tunisia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Ben Azouz","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Internal Security Forces Hospital La Marsa, Tunis, Tunisia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hedi","family":"Douggui","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Internal Security Forces Hospital La Marsa, Tunis, Tunisia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taieb","family":"Jomni","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Internal Security Forces Hospital La Marsa, Tunis, Tunisia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","author":"Ellis C.R.","year":"2024","unstructured":"Ellis C.R.; Azmat C.E.; Adalimumab. In: StatPearls. Treasure Island, FL: StatPearls Publishing  Internet2024"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1093\/ecco-jcc\/jjz180","volume":"14","author":"Torres J.","year":"2020","unstructured":"Torres J.; Bonovas S.; Doherty G.; ECCO Guidelines on therapeutics in Crohn\u2019s disease: Medical treatment. J Crohn\u2019s Colitis  2020,14(1),4-22","journal-title":"J Crohn\u2019s Colitis"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"363","DOI":"10.34067\/KID.0000000000000063","volume":"4","author":"Usui J.","year":"2023","unstructured":"Usui J.; Salvatore S.P.; Yamagata K.; Seshan S.V.; Clinicopathologic spectrum of renal lesions following anti-TNF-\u03b1 inhibitor therapy: A single center experience. Kidney360  2023,4(3),363-373","journal-title":"Kidney360"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/j.autrev.2014.05.005","volume":"13","author":"Piga M.","year":"2014","unstructured":"Piga M.; Chessa E.; Ibba V.; Biologics-induced autoimmune renal disorders in chronic inflammatory rheumatic diseases: Systematic literature review and analysis of a monocentric cohort. Autoimmun Rev  2014,13(8),873-879","journal-title":"Autoimmun Rev"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/art.37715","volume":"65","author":"Jennette J.C.","year":"2013","unstructured":"Jennette J.C.; Falk R.J.; Bacon P.A.; 2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum  2013,65(1),1-11","journal-title":"Arthritis Rheum"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"11","DOI":"10.2478\/rir-2023-0003","volume":"4","author":"Sun X.J.","year":"2023","unstructured":"Sun X.J.; Li Z.Y.; Chen M.; Pathogenesis of anti-neutrophil cytoplasmic antibody-associated vasculitis. Rheumatol Immunol Res  2023,4(1),11-21","journal-title":"Rheumatol Immunol Res"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1186\/s12882-021-02502-y","volume":"22","author":"Morimoto K.","year":"2021","unstructured":"Morimoto K.; Kanzaki G.; Niikura T.; Acute tubulointerstitial nephritis associated with antineutrophil cytoplasmic antibody following cimetidine treatment: A case report. BMC Nephrol  2021,22(1),294","journal-title":"BMC Nephrol"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/s13730-016-0237-y","volume":"6","author":"Nishimura S.","year":"2017","unstructured":"Nishimura S.; Nakao K.; Takeda M.; Antithyroid drug-associated MPO-ANCA-positive tubulointerstitial nephritis in a type 2 diabetes patient: A case report. CEN Case Rep  2017,6(1),22-28","journal-title":"CEN Case Rep"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"3551","DOI":"10.1007\/s10067-022-06264-2","volume":"41","author":"He X.","year":"2022","unstructured":"He X.; Wen Y.; Hu R.; Interstitial nephritis without glomerulonephritis in ANCA-associated vasculitis: A case series and literature review. Clin Rheumatol  2022,41(11),3551-3563","journal-title":"Clin Rheumatol"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"46","DOI":"10.5414\/CNCS109805","volume":"7","author":"Plafkin C.","year":"2019","unstructured":"Plafkin C.; Zhong W.; Singh T.; ANCA vasculitis presenting with acute interstitial nephritis without glomerular involvement. Clin Nephrol Case Stud  2019,7(1),46-50","journal-title":"Clin Nephrol Case Stud"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"e5598","DOI":"10.7759\/cureus.5598","volume":"11","author":"Chandra T.","year":"2019","unstructured":"Chandra T.; Tabanor-Gayle J.A.; Lakshminarayanan S.; Adalimumab-induced anti-neutrophilic cytoplasmic antibody vasculitis: A rare complication of an increasingly common treatment. Cureus  2019,11(9),e5598","journal-title":"Cureus"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.nefroe.2017.09.006","volume":"37","author":"Varas C.M.","year":"2017","unstructured":"Varas C.M.; Heras M.; Saiz A.; Antineutrophil cytoplasmic antibodies associated vasculitis in patient with Crohn\u2019s disease treated with adalimumab. Nefrolog\u00eda (Engl Ed)  2017,37(5),560-561","journal-title":"Nefrolog\u00eda (Engl Ed)"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"e11","DOI":"10.1053\/j.ajkd.2007.10.043","volume":"51","author":"Simms R.","year":"2008","unstructured":"Simms R.; Kipgen D.; Dahill S.; Marshall D.; Rodger R.S.; ANCA-associated renal vasculitis following anti-tumor necrosis factor alpha therapy. Am J Kidney Dis  2008,51(3),e11-e14","journal-title":"Am J Kidney Dis"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.nephro.2009.03.005","volume":"5","author":"Fournier A.","year":"2009","unstructured":"Fournier A.; Nony A.; Rifard K.; Vascularite \u00e0 anticorps anticytoplasme des polynucl\u00e9aires neutrophiles chez une patiente trait\u00e9e par adalimumab pour une polyarthrite rhumato\u00efde. Nephrol Ther  2009,5(7),652-657","journal-title":"Nephrol Ther"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"2848","DOI":"10.1097\/CM9.0000000000000539","volume":"132","author":"Weng C.H.","year":"2019","unstructured":"Weng C.H.; Liu Z.C.; Drug-induced anti-neutrophil cytoplasmic antibody-associated vasculitis. Chin Med J (Engl)  2019,132(23),2848-2855","journal-title":"Chin Med J (Engl)"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1007\/s13730-021-00620-y","volume":"11","author":"Hishida E.","year":"2022","unstructured":"Hishida E.; Kobayashi T.; Ono Y.; Tubulointerstitial nephritis in antineutrophil cytoplasmic antibody-associated vasculitis with monoclonal gammopathy. CEN Case Rep  2022,11(1),36-42","journal-title":"CEN Case Rep"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.reumae.2017.03.011","volume":"15","author":"Castro Corredor D.","year":"2019","unstructured":"Castro Corredor D.; S\u00e1nchez de la Nieta M.D.; de Lara Sim\u00f3n I.M.; Acute tubulointerstitial nephritis in an HLA-B27-positive patient with axial spondyloarthritis being treated with adalimumab. Reumatol Cl\u00edn (Engl Ed)  2019,15(3),179-181","journal-title":"Reumatol Cl\u00edn (Engl Ed)"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"154","DOI":"10.4172\/1758-4272.1000151","volume":"12","author":"Mogairen S.M.A.","year":"2017","unstructured":"Mogairen S.M.A.; Adalimumab induced chronic interstitial nephritis: a controlled blinded trial in mice. Int J Clin Rheumatol  2017,12(6),154","journal-title":"Int J Clin Rheumatol"},{"key":"ref=19","first-page":"381","volume":"81","author":"Elaziz M.M.A.","year":"2018","unstructured":"Elaziz M.M.A.; Fayed A.; Patterns of renal involvement in a cohort of patients with inflammatory bowel disease in Egypt. Acta Gastroenterol Belg  2018,81(3),381-385","journal-title":"Acta Gastroenterol Belg"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.nephro.2018.07.406","volume":"15","author":"Treffel M.","year":"2019","unstructured":"Treffel M.; Champigneulle J.; Meibody F.; Laurain E.; Frimat L.; Busby-Venner H.; Tubulointerstitiel nephritis and Crohn\u2019s disease, nephrotoxicity or extraintestinal manifestation of Crohn\u2019s disease? About a case. Nephrol Ther  2019,15(1),59-62","journal-title":"Nephrol Ther"}],"container-title":["Current Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0115748863362460250220172535","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/240642\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0115748863362460250220172535","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T09:14:37Z","timestamp":1791882877000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/240642\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0115748863362460250220172535","relation":{},"ISSN":["1574-8863"],"issn-type":[{"value":"1574-8863","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Double blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2024-10-28","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-01-05","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-01-16","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-02","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e15748863362460"}}